We provide you with 20 years of free, institutional-grade data for RNA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RNA. Explore the full financial landscape of RNA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Avidity Biosciences, Inc(NASDAQ:RNA) 
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment...
Website: http://www.aviditybiosciences.com
Founded: 2012
CEO: Sarah Boyce
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about RNA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.